Subsequent Events (Details Narrative) - USD ($)	3 Months Ended
Jul. 31, 2017	Nov. 27, 2017	Oct. 31, 2017
Common Stock; authorized	2,450,000	750,000,000	2,450,000
Hema Diagnostic Systems, LLC
Advances	$ 36,757

The cash inflow associated with the amount received by a corporation from a shareholder during the period.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3255-108585

Name:	us-gaap_ProceedsFromContributedCapital
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration